Skye is planning to initiate a Phase 2b clinical trial in obesity for nimacimab with ENHANZE in the middle of 2026. This study will also assess the combination of nimacimab and a GLP-1R agonist.
5don MSNOpinion
How FOMO Is Turning AI Into a Cybersecurity Nightmare
Every CEO I meet thinks their AI strategy is simple: implement tools, boost productivity, and stay competitive. The reality ...
The vulnerability, tracked as CVE-2025-68664 and dubbed “LangGrinch,” has a Common Vulnerability Scoring System score of 9.3.
The transition from basic RAG to AI Infrastructure powered by Context Engineering is not a future scenario, it is today’s ...
Agreement supports development and commercialization of higher-dose, subcutaneous administration strategies for nimacimab SAN DIEGO, Jan. 5, 2026 /PRNewswire/ -- Halozyme ...
China’s rapid advances in semiconductor development are being fueled by a previously undocumented rule that requires local ...
In the Air Force, Dr. Alex Schloe used to see 22 patients a day for a primary care appointment where he would spend five to ...
The Federal Reserve plans a $6.8B repo operation on December 22 to ease year-end liquidity pressures, its first since 2020.
"Grounded AI is non-negotiable, because accuracy isn’t optional when we’re doing million-dollar transformation projects ...
You can get a good sense of what people care about by what they read, what they write and the topics they choose. In that ...
This strategic partnership enhances the industrial potential and the value of the portfolio projects, reinforces Eni's ...
3000 Grapevine Mills Parkway, Ste. 343A, Grapevine 631 E. Southlake Blvd., Ste. F, Southlake 3000 Grapevine Mills Parkway, Ste. 500, Grapevine 1041 E. Southlake Blvd., Stes. 100 and 110, Southlake ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results